POTSPOTS← ALL GUIDES
GUIDE

POTS Medications: What Each One Does and What the Trials Show

Propranolol, pyridostigmine, midodrine, fludrocortisone, ivabradine and others: how they work, the evidence behind each, side effects, and why none is FDA-approved for POTS.

By Kaustubh Dabhadkar, preventive cardiologist · Published October 9, 2026

Every medicine used for POTS is prescribed off-label. A check of FDA drug labels found that none of propranolol, midodrine, ivabradine, pyridostigmine, fludrocortisone, droxidopa or modafinil lists POTS as an indication. This page describes what trials found. It does not tell you what to take.

  • Propranolol (low dose)HRS Class IIb

    Heart rate: Slows heart rate

    54 PEOPLE · RAJ 2009

  • IvabradineNewer than HRS 2015

    Heart rate: Slows the sinus node directly

    22 PEOPLE · TAUB 2021

  • PyridostigmineHRS Class IIb

    Heart rate: Boosts acetylcholine signaling

    17 PEOPLE · RAJ 2005

  • MidodrineHRS Class IIb

    Blood vessels: Tightens blood vessels

    20 PEOPLE · ROSS 2014

  • FludrocortisoneHRS Class IIb

    Blood volume: Retains salt, expands volume

    No randomized trialFreitas 2000, open-label, 11 women

NO MEDICINE HAS FDA APPROVAL FOR POTS

Every one of these is off-label for POTS. One dot is one person in the largest randomized trial we found.

What the trials found

  • Propranolol. 20 mg lowered standing heart rate and improved symptoms at 2 hours. 80 mg lowered the rate more but helped symptoms less (Raj 2009).
  • Pyridostigmine. 30 mg lowered standing heart rate from 111 to 100 bpm at 2 hours (Raj 2005).
  • Midodrine. Symptom benefit ranged from 46% to 91% across 14 studies, with stronger results in children (Kwok 2026).
  • Fludrocortisone. No randomized POTS trial was found.
  • Ivabradine. Improved heart rate and function in 22 patients with hyperadrenergic POTS (Taub 2021). It arrived after the HRS 2015 statement.

Clinicians often match the drug to the pattern, as the grid shows. That matching comes from clinical practice and has not been tested head to head in large trials.

What the big reviews say

A 2025 systematic review of 21 randomized trials (750 patients) called for large trials before any drug can be called first line. A 2024 review found ivabradine and midodrine had the highest rates of symptom improvement and beta-blockers the largest drops in heart rate variability. Both carry real uncertainty.

What to avoid

MEDICINES THAT CAN MAKE POTS WORSE

  • HRS Class III, harm

    Norepinephrine reuptake blockers

    Includes some antidepressants and ADHD medicines

  • Check first

    Stimulants

    Can raise heart rate

  • Check first

    Decongestants

    Can raise heart rate

Do not stop a prescribed medicine on your own. Review the full list with a pharmacist or your doctor.

Side effects to watch

WHAT TO WATCH FOR

  • Tiredness
  • Low blood pressure
  • Wheezing in asthma
  • Unsafe to stop suddenly
Report side effects to your prescriber. Changes to a medicine belong in that conversation.

Using this page

Print the visit checklist, write down the symptom that bothers you most, and ask which option fits your blood pressure and history. Track the result with repeat stand tests.

NOTE

This page informs and does not diagnose. Only a clinician who can examine you and see your whole history can interpret your numbers.

Want a record to bring to your visit? The POTS app guides the stand test at home and graphs your heart rate. See the app

© 2026 CORDOC LLCGuidesWalk-throughCheck numbersTreatmentsResearchVisit prepResourcesThe appPrivacyTerms